Issue 8, 2017

Aminoglycoside-based novel probes for bacterial diagnostic and therapeutic applications

Abstract

Specific detection of pathogens has long been recognized as a vital strategy in the control of infectious diseases. Two novel theranostic neomycin analogs exhibit efficient targeting, labelling and killing of broad spectrum bacteria while not damaging macrophage-like cells. Furthermore, lipidated probe 2 clearly showed antibacterial activity against methicillin-resistant S. aureus.

Graphical abstract: Aminoglycoside-based novel probes for bacterial diagnostic and therapeutic applications

Supplementary files

Article information

Article type
Communication
Submitted
14 Oct 2016
Accepted
01 Dec 2016
First published
01 Dec 2016

Chem. Commun., 2017,53, 1366-1369

Aminoglycoside-based novel probes for bacterial diagnostic and therapeutic applications

Q. Zhang, Q. Wang, S. Xu, L. Zuo, X. You and H. Hu, Chem. Commun., 2017, 53, 1366 DOI: 10.1039/C6CC08292K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements